By Emily Field (March 21, 2019, 8:19 PM EDT) -- Career scientist and physician Dr. Norman Sharpless will leave his post as the head of the National Cancer Institute to take over the U.S. Food and Drug Administration when Scott Gottlieb steps down in April.
Here's what you should know about the new interim commissioner.
Sharpless is likely to continue the FDA's focus on tobacco control and youth vaping. As a founder of two biotech companies, he also brings a knowledge of the drug development process and an understanding of industry. His background indicates he will continue the FDA's recent efforts to update the drug approval process, according to experts....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!